Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases

References

• National Institute for Health and Care Excellence (NICE). Electrochemotherapy for primary basal cell carcinoma and primary squamous cell carcinoma; [Internet] 2014. Available from: www.nice.org.uk.
   Google Scholar
• National Institute for Health and Care Excellence (NICE). Electrochemotherapy for metastases in the skin from tumours of non-skin origin and melanoma; 2013. Available from: http://publicationsniceorguk/electrochemotherapy-for-metastases-in-the-skin-from-tumours-of-non-skin-origin-and-melanoma-ipg446.
   Google Scholar
• Kee S, Gehl J, Lee E. Clinical Aspects of Electroporation. New York (NY): Springer; 2011.
   Google Scholar
• Belehradek M, Domenge C, Luboinski B, et al. Electrochemotherapy, a new antitumor treatment. First clinical phase I–II trial. Cancer. 1993;72:3694–3700.
   PubMed Web of Science ®Google Scholar
• Heller R, Jaroszeski MJ, Reintgen DS, et al. Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer. 1998;83:148–157.
   PubMed Web of Science ®Google Scholar
• Marty M, Sersa G, Garbay JR, et al. Electrochemotherapy – an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Ejc Supplements. 2006;4:3–13.
   Google Scholar
• Campana LG, Mocellin S, Basso M, et al. Bleomycin-based electrochemotherapy: clinical outcome from a single institution's experience with 52 patients. AnnSurgOncol. 2009;16:191–199.
   Google Scholar
• Matthiessen LW, Chalmers RL, Sainsbury DC, et al. Management of cutaneous metastases using electrochemotherapy. Acta Oncol. 2011;50:621–629.
   PubMed Web of Science ®Google Scholar
• Matthiessen LW, Johannesen HH, Hendel HW, et al. Electrochemotherapy for large cutaneous recurrence of breast cancer: a phase II clinical trial. Acta Oncol. 2012;51:713–721.
   PubMed Web of Science ®Google Scholar
• Curatolo P, Quaglino P, Marenco F, et al. Electrochemotherapy in the treatment of Kaposi sarcoma cutaneous lesions: a two-center prospective phase II trial. Ann Surg Oncol. 2012;19:192–198.
   PubMed Web of Science ®Google Scholar
• Campana LG, Valpione S, Mocellin S, et al. Electrochemotherapy for disseminated superficial metastases from malignant melanoma. Br J Surg. 2012;99:821–830.
   PubMed Web of Science ®Google Scholar
• Campana LG, Valpione S, Falci C, et al. The activity and safety of electrochemotherapy in persistent chest wall recurrence from breast cancer after mastectomy: a phase-II study. Breast Cancer Res Treat. 2012;134:1169–1178.
   PubMed Web of Science ®Google Scholar
• Bertino G, Sersa G, De Terlizzi F, et al. European research on electrochemotherapy in head and neck cancer (EURECA) project: results of the treatment of skin cancer. Eur J Cancer. 2016;63:41–52.
   PubMed Web of Science ®Google Scholar
• Mir LM, Gehl J, Sersa G, et al. Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or non-invasive electrodes. Eur J Cancer Suppl. 2006;4:14–25.
   Web of Science ®Google Scholar
• Campana LG, Testori A, Mozzillo N, et al. Treatment of metastatic melanoma with electrochemotherapy. J Surg Oncol. 2014;109:301–307.
   PubMed Web of Science ®Google Scholar
• Curatolo P, Miraglia E, Rotunno R, et al. Electrochemotherapy: a valid treatment for Gorlin-Goltz syndrome. Acta Dermatovenerol Croat. 2013;21:132–133.
   PubMed Web of Science ®Google Scholar
• Quaglino P, Mortera C, Osella-Abate S, et al. Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases. AnnSurgOncol. 2008;15:2215–2222.
   Google Scholar
• Campana LG, Testori A, Curatolo P, et al. Treatment efficacy with electrochemotherapy: a multi-institutional prospective observational study on 376 patients with superficial tumors. Eur J Surg Oncol. 2016;42:1914–1923.
   PubMed Web of Science ®Google Scholar
• Spratt DE, Gordon Spratt EA, Wu S, et al. Efficacy of skin-directed therapy for cutaneous metastases from advanced cancer: a meta-analysis. J Clin Oncol. 2014;32:3144–3155.
   PubMed Web of Science ®Google Scholar
• Kunte C, Letule V, Gehl J, et al. Electrochemotherapy in the treatment of metastatic malignant melanoma: a prospective cohort study by InspECT. Br J Dermatol. 2017;176:1475–1485.
   PubMed Web of Science ®Google Scholar
• Whelan MC, Larkin JO, Collins CG, et al. Effective treatment of an extensive recurrent breast cancer which was refractory to multimodal therapy by multiple applications of electrochemotherapy. Eur J Cancer Suppl. 2006;4:32–34.
   Web of Science ®Google Scholar
• Gehl J, Geertsen PF. Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy. Melanoma Res. 2000;10:585–589.
   PubMed Web of Science ®Google Scholar
• Gehl J, Skovsgaard T, Mir LM. Vascular reactions to in vivo electroporation: characterization and consequences for drug and gene delivery. Biochim Biophys Acta. 2002;1569:51–58.
   PubMed Web of Science ®Google Scholar
• Markelc B, Sersa G, Cemazar M. Differential mechanisms associated with vascular disrupting action of electrochemotherapy: intravital microscopy on the level of single normal and tumor blood vessels. PLoS One. 2013;8:e59557.
   PubMed Web of Science ®Google Scholar
• Sersa G, Jarm T, Kotnik T, et al. Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. Br J Cancer. 2008;98:388. 98:
   PubMed Web of Science ®Google Scholar
• Andersen MH, Gehl J, Reker S, et al. Dynamic changes of specific T cell responses to melanoma correlate with IL-2 administration. Semin Cancer Biol. 2003;13:449–459.
   PubMed Web of Science ®Google Scholar
• Calvet CY, Famin D, Andre FM, et al. Electrochemotherapy with bleomycin induces hallmarks of immunogenic cell death in murine colon cancer cells. Oncoimmunology. 2014;3:e28131.
   PubMed Web of Science ®Google Scholar
• Sersa G, Teissie J, Cemazar M, et al. Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer. Cancer Immunol Immunother. 2015;64:1315–1327.
   PubMed Web of Science ®Google Scholar
• Mozzillo N, Simeone E, Benedetto L, et al. Assessing a novel immuno-oncology-based combination therapy: ipilimumab plus electrochemotherapy. Oncoimmunology. 2015;4:e1008842.
   PubMed Web of Science ®Google Scholar
• Calvet CY, Mir LM. The promising alliance of anti-cancer electrochemotherapy with immunotherapy. Cancer Metastasis Rev. 2016;35:165–177.
   PubMed Web of Science ®Google Scholar
• Falk H, Lambaa S, Johannesen HH, et al. Electrochemotherapy and calcium electroporation inducing a systemic immune response with local and distant remission of tumors in a patient with malignant melanoma – a case report. Acta Oncol. 2017;56:1126–1131.
   PubMed Web of Science ®Google Scholar
• Stratigos A, Garbe C, Lebbe C, et al. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline. Eur J Cancer. 2015;51:1989–2007.
   PubMed Web of Science ®Google Scholar
• Quaglino P, Matthiessen LW, Curatolo P, et al. Predicting patients at risk for pain associated with electrochemotherapy. Acta Oncol. 2015;54:298–306.
   PubMed Web of Science ®Google Scholar
• Queirolo P, Marincola F, Spagnolo F. Electrochemotherapy for the management of melanoma skin metastasis: a review of the literature and possible combinations with immunotherapy. Arch Dermatol Res. 2014;306:521–526.
   PubMed Web of Science ®Google Scholar
• Heppt MV, Eigentler TK, Kahler KC, et al. Immune checkpoint blockade with concurrent electrochemotherapy in advanced melanoma: a retrospective multicenter analysis. Cancer Immunol Immunother. 2016;65:951–959.
   PubMed Web of Science ®Google Scholar
• Gehl J. [Investigational treatment of cancer using electrochemotherapy, electrochemoimmunotherapy and electro-gene transfer]. Ugeskr Laeger. 2005;167:3156–3159.
   PubMedGoogle Scholar
• Matthiessen LW, Johannesen HH, Skougaard K, et al. Dual time point imaging fluorine-18 flourodeoxyglucose positron emission tomography for evaluation of large loco-regional recurrences of breast cancer treated with electrochemotherapy. Radiol Oncol. 2013;47:358–365.
   PubMed Web of Science ®Google Scholar
• Kendler M, Micheluzzi M, Wetzig T, et al. Electrochemotherapy under tumescent local anesthesia for the treatment of cutaneous metastases. Dermatol Surg. 2013;39:1023–1032.
   PubMed Web of Science ®Google Scholar
• Gothelf A, Mir LM, Gehl J. Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation. Cancer Treat Rev. 2003;29:371–387.
   PubMed Web of Science ®Google Scholar
• Groselj A, Krzan M, Kosjek T, et al. Bleomycin pharmacokinetics of bolus bleomycin dose in elderly cancer patients treated with electrochemotherapy. Cancer Chemother Pharmacol. 2016;77:939–947.
   PubMed Web of Science ®Google Scholar
• Garbe C, Peris K, Hauschild A, et al. Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2016. Eur J Cancer. 2016;63:201–217.
   PubMed Web of Science ®Google Scholar
• Plaschke CC, Bertino G, McCaul JA, et al. European research on electrochemotherapy in head and neck cancer (EURECA) project: results from the treatment of mucosal cancers. Eur J Cancer. 2017;87:172–181.
   PubMed Web of Science ®Google Scholar